FutureMeds S.R.L. /ID# 279217

Galati 800183

1 studies enrolling now · 1 studies all time

What they study most

Atopic Dermatitis

Studies at this site

• A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab — Recruiting now